000297981 001__ 297981
000297981 005__ 20250624144159.0
000297981 0247_ $$2doi$$a10.1007/s00066-024-02352-1
000297981 0247_ $$2pmid$$apmid:39821412
000297981 0247_ $$2ISSN$$a0179-7158
000297981 0247_ $$2ISSN$$a1439-099X
000297981 037__ $$aDKFZ-2025-00156
000297981 041__ $$aEnglish
000297981 082__ $$a610
000297981 1001_ $$00009-0007-4463-5314$$aLeiss, Sophia M$$b0
000297981 245__ $$aAnalysis of radiation oncology integration within general practitioners' daily patient care: a cross-sectional survey in Germany.
000297981 260__ $$aHeidelberg$$bSpringer Medizin$$c2025
000297981 3367_ $$2DRIVER$$aarticle
000297981 3367_ $$2DataCite$$aOutput Types/Journal article
000297981 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1750768884_16792
000297981 3367_ $$2BibTeX$$aARTICLE
000297981 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000297981 3367_ $$00$$2EndNote$$aJournal Article
000297981 500__ $$aVolume 201, pages 723–731, (2025)
000297981 520__ $$aGeneral practitioners (GPs) play a crucial role in providing interdisciplinary care for radiation oncology patients. This study aims to understand the specific needs and challenges faced by general practitioners in Germany when treating oncology patients.A comprehensive web-based questionnaire with 24 items was disseminated to GPs in Germany via email using survio.com. The survey collected data on demographics, qualifications, clinical experiences, decision-making involvement, and symptom recognition. It specifically examined post-radiotherapy care and the use of specialized palliative homecare networks (SAPV). Statistical analyses were descriptive. The survey was open from July 4 to August 9, 2023.A notable majority of general practitioners displayed confidence in their understanding of cancer-related symptoms, with over half (54.6%) rating their knowledge with 4 out of 5. This level of self-assessed expertise extended to their capacity to address the needs of cancer patients (53.8%), although 67% express a need for further education in specifically radiotherapeutic side effects. Satisfaction with SAPV networks was high, and 72.3% of respondents were actively involved in palliative care, compared to only 45.6% in managing radiation therapy. Notable challenges included inadequate communication with specialists, insufficient staffing, and under-recognition of GPs' roles in oncology care.The study highlights a paradox where GPs show high engagement in palliative care but limited involvement in radiation therapy management due to communication gaps and professional development needs. Addressing these disparities through targeted initiatives and fostering a collaborative care model is essential to amplify the important role of GPs, ensuring more integrated and effective patient care.
000297981 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000297981 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000297981 650_7 $$2Other$$aCancer patient management
000297981 650_7 $$2Other$$aHealthcare survey
000297981 650_7 $$2Other$$aInterdisciplinary collaboration
000297981 650_7 $$2Other$$aPrimary care integration
000297981 650_7 $$2Other$$aRadiotherapy access
000297981 7001_ $$aHou, Helen X$$b1
000297981 7001_ $$aPigorsch, Steffi$$b2
000297981 7001_ $$aBorm, Kai$$b3
000297981 7001_ $$aPeeken, Jan$$b4
000297981 7001_ $$aSchneider, Antonius$$b5
000297981 7001_ $$0P:(DE-HGF)0$$aCombs, Stephanie$$b6
000297981 7001_ $$aDinkel, Andreas$$b7
000297981 7001_ $$aBernhardt, Denise$$b8
000297981 773__ $$0PERI:(DE-600)2003907-4$$a10.1007/s00066-024-02352-1$$p723–731$$tStrahlentherapie und Onkologie$$v201$$x0179-7158$$y2025
000297981 909CO $$ooai:inrepo02.dkfz.de:297981$$pVDB
000297981 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000297981 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000297981 9141_ $$y2025
000297981 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000297981 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000297981 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSTRAHLENTHER ONKOL : 2022$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000297981 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000297981 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK Koordinierungsstelle München$$x0
000297981 980__ $$ajournal
000297981 980__ $$aVDB
000297981 980__ $$aI:(DE-He78)MU01-20160331
000297981 980__ $$aUNRESTRICTED